Glucocorticoid-Induced Muscle Satellite Cell-Derived Extracellular Vesicles Mediate Skeletal Muscle Atrophy via the miR-335-5p/MAPK11/iNOS Pathway

Biomolecules. 2025 Jul 24;15(8):1072. doi: 10.3390/biom15081072.

Abstract

Prolonged high-dose administration of synthetic glucocorticoids (GCs) leads to limb muscle atrophy and weakness, yet its underlying mechanisms remain incompletely understood. Muscle fibers and muscle satellite cells (MSCs) are essential for skeletal muscle development and associated pathologies. This study demonstrates that dexamethasone (Dex) induced MSC-derived extracellular vesicles (EVs) impair myogenesis in muscle fiber-like cells (MFLCs) via inducible nitric oxide synthase (iNOS) suppression. High-throughput sequencing revealed a marked upregulation of miR-335-5p in MSC-derived EVs following Dex treatment. Mechanistically, EV miR-335-5p targeted MAPK11, leading to iNOS downregulation and subsequent UPS activation in MFLCs, which directly promoted muscle protein degradation. Collectively, our findings identify the EV miR-335-5p/MAPK11/iNOS axis as a critical mediator of GC-induced muscle atrophy, offering novel insights into therapeutic strategies targeting EV-mediated signaling in muscle wasting disorders.

Keywords: extracellular vesicles; glucocorticoids; inducible nitric oxide synthase; miRNA; muscle satellite cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Dexamethasone / pharmacology
  • Extracellular Vesicles* / drug effects
  • Extracellular Vesicles* / metabolism
  • Glucocorticoids* / pharmacology
  • Humans
  • Mice
  • MicroRNAs* / genetics
  • MicroRNAs* / metabolism
  • Muscle, Skeletal / drug effects
  • Muscle, Skeletal / metabolism
  • Muscle, Skeletal / pathology
  • Muscular Atrophy* / chemically induced
  • Muscular Atrophy* / genetics
  • Muscular Atrophy* / metabolism
  • Muscular Atrophy* / pathology
  • Nitric Oxide Synthase Type II* / genetics
  • Nitric Oxide Synthase Type II* / metabolism
  • Satellite Cells, Skeletal Muscle* / drug effects
  • Satellite Cells, Skeletal Muscle* / metabolism
  • Signal Transduction / drug effects

Substances

  • MicroRNAs
  • Glucocorticoids
  • Dexamethasone
  • Nitric Oxide Synthase Type II